Giovanna Gallo | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication	JOURNAL OF CLINICAL MEDICINE	2024
Obesity and Overweight: The “Elephant in the Room” That We can No Longer Ignore: Time to SELECT Treatments	HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION	2024
New Insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
Mitochondrial Dysfunction in Heart Failure: From Pathophysiological Mechanisms to Therapeutic Opportunities	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
A Mobile App-based Approach in Cardiovascular Disease Prevention: A Prospective Randomized Study	HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION	2024
What about chronotropic incompetence in heart failure with mildly reduced ejection fraction? Clinical and prognostic implications from the Metabolic Exercise combined with Cardiac and Kidney Indexes score dataset	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY	2024
Hypertension and Heart Failure: From Pathophysiology to Treatment	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
Asymptomatic hyperuricemia: to treat or not a threat? A clinical and evidence-based approach to the management of hyperuricemia in the context of cardiovascular diseases	JOURNAL OF HYPERTENSION	2024
Position statement of the Italian Society of Cardiovascular Prevention (SIPREC) and Italian Heart Failure Association (ITAHFA) on cardiac rehabilitation and protection programs as a cornerstone of secondary prevention after myocardial infarction or revascularization	HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION	2024
Update on obesity and cardiovascular risk: from pathophysiology to clinical management	NUTRIENTS	2024
Chronotropic incompetence across heart failure categories	EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY	2024
New insight in cardiorenal syndrome: from biomarkers to therapy	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
Atrial natriuretic peptide stimulates autophagy/mitophagy and improves mitochondrial function in chronic heart failure	CELLULAR AND MOLECULAR LIFE SCIENCES	2023
Influence of exertional oscillatory breathing and its temporal behavior in patients with heart failure and reduced ejection fraction	INTERNATIONAL JOURNAL OF CARDIOLOGY	2023
Cardiovascular risk and the COVID-19 pandemic: A retrospective observational study in a population of healthcare professionals	NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES	2023
Polymorphic variants at NDUFC2, encoding a mitochondrial complex I subunit, associate with cardiac hypertrophy in human hypertension	MOLECULAR MEDICINE	2023
Effects of two-month treatment with a mixture of natural activators of autophagy on oxidative stress and arterial stiffness in patients with essential hypertension: A pilot study	NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES	2023
From cardiovascular system to brain, the potential protective role of mas receptors in COVID-19 infection	EUROPEAN JOURNAL OF PHARMACOLOGY	2023

Gruppi di ricerca

Ipertensione arteriosa e prevenzione cardiovascolare

Disregolazione neurormonale nelle malattie cardiovascolari

Disfunzione mitocondriale e stress ossidativo nelle malattie cardiovascolari